TADALAFIL | TADALAFIL | ATC C02KX52 ATC G04CB51 ATC C02KX54 ATC G04BE08 ATC G04CA54
GENITO ERECTILE DYSFUNCTION (THERAPEUTIC) (CGMP)-SPECIFIC PHOSPHODIESTERASE TYPE 5 INHIBITORS VASOCONSTRICTOR AGENTS TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) | ORAL | Tmax 2 HOUR VD 63 LITER PPB 94 PERCENT Cl 2.5 LITER / HOUR HT 17.5 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 5 PDB 1XOZ (CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH TADALAFIL) LIGAND CODE = CIA (link to the list of PDB complexes) Download experimental 3D coordinates of CIA with added hydrogens | cGMP-specific 3,5-cyclic phosphodiesterase UNIPROT O76074 PDE5A more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |